Pfizer claims study success for drug key to Arena buyout
Dive Brief:
Pfizer said Wednesday an experimental drug central to its $7 billion purchase of Arena Pharmaceuticals succeeded in a crucial Phase 3 trial in patients...
Continue Reading →
